Compounds > n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
Page last updated: 2024-09-05

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Glioblastoma

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Glioblastoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Andrade, AF; Becker, AP; Bidinotto, LT; Carlotti, CG; Nandhu, MS; Neder, L; Pezuk, JA; Scrideli, CA; Suazo, VK; Teixeira, SA; Tone, LG; Viapiano, MS1

Other Studies

1 other study(ies) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Glioblastoma

ArticleYear
The Carbonic Anhydrase Inhibitor E7070 Sensitizes Glioblastoma Cells to Radio- and Chemotherapy and Reduces Tumor Growth.
    Molecular neurobiology, 2021, Volume: 58, Issue:9

    Topics: Apoptosis; Brain Neoplasms; Carbonic Anhydrase Inhibitors; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; Humans; Sulfonamides

2021